Issue of Equity
2008年7月10日 - 12:26AM
RNSを含む英国規制内ニュース (英語)
Eden Research plc ("Eden" or the "Company")
Issue of Equity
Eden Research, a UK leading agrochemical and development company, announces that it has issued
2,325,650 ordinary shares of 1p each pursuant to the exercise of warrants by long term lenders of
the Company. The aggregate consideration of GBP 428,945 arising from the exercise of warrants
will be offset against their loans.
Tim Griffiths, CEO of Eden Research plc said:
"This exercise of warrants reduces Eden Research's creditor position and it reinforces the
lenders' commitment to the Company. The lenders have agreed to be locked in for a period of 12
months from the date of issue."
Separately, the Company announces that it has issued 50,000 ordinary shares of 1p each pursuant to
the exercise of options on 8 July 2008.
Following these issues, Eden Research has 56,226,612 ordinary shares in issue.
Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Matthew Robinson/Rose Herbert, FinnCap
T : 020 7600 1658
Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113
About Eden Research plc
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the
development of agrochemical products and intellectual property through licensing and marketing
agreements.
Eden is focused on developing products for the agricultural sector through the application of
terpene chemistry and other patented environmentally friendly technologies. Eden is currently
working alongside universities and partner companies in developing its product portfolio towards
commercialisation.
For further information please visit www.edenresearch.com.
Eden Research plc
Edenville (LSE:EDE)
過去 株価チャート
から 5 2024 まで 6 2024
Edenville (LSE:EDE)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Edenville (ロンドン証券取引所): 0 recent articles
その他のEden Research Plcニュース記事